logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PE/iFluor® 700 Anti-human CD6 Antibody
HI210
HI210 is an anti-human monoclonal antibody that is specific for the CD6 antigen. CD6 (sometimes called TP120, OX52 or T12) is a 100 - 130 kD single-pass type I membrane protein that is located on the surface of cells such as T cells and B cells. In some organisms, CD6 acts to positively regulate T cell proliferation and enhances cytokine production involved in inflammatory response. Additionally, it acts in critical cellular pathways, in particular, the lipopolysaccharide-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with vital macromolecules/ligands such as CD166 (ALCAM), gp40 and gp90. CD6 is a fairly uncommon antibody target, with a little more than 1200 publications in the last decade. Even still, CD6 is commonly used in flow cytometry applications as a phenotypic marker for differentiation of cell types, specifically in the study of immunology. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 700 (ex/em = 566/708 nm). It is compatible with the 561 nm laser and 710/50 nm bandpass filter (for example, as in the BD LSRFortessa™ X-20).
product image
product image
CatalogSize
Price
Quantity
100601X025 tests
Price
100601X1100 tests
Price
100601X2500 tests
Price
 
Antibody properties

Other namesT12; TP120
CloneHI210
Hostmouse
Isotypemouse IgG1
Reactivityhuman
Spectral properties

Absorbance (nm)566
Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)708
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 10, 2025